SCM Pharma will launch formulation development services following the acquisition of new facilities through a collaboration with the University of Sunderland. SCM Pharma’s preclinical capability will be housed in the formulation and analytical labs at the University of Sunderland’s new science complex. The launch follows a two-year development project with Mitovie Pharma, under which SCM provides formulation support for one of its four lead candidates. Michael Hawthorne, chief executive officer...